StockData
DarioHealth Corp. logo

DarioHealth Corp. (DRIO) stock

DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.15−0.11 (-8.73%)

Close on Nov 16, 2026Market cap $11.27MP/E 0.3Yield –

DarioHealth r&d expenses

Research and development expenses are spending on new products and technology.

DarioHealth's R&D Expenses for the twelve months ending Jun 30, 2026 was $10.45M, down 43.7% year over year. For fiscal 2025 it was $13.79M, down 43.0% from the year before. Over ten years it grew 18.3% a year on average. The highest annual figure on record is $24.18M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.79M-43.0%
FY2024Dec 31, 2024$24.18M+19.4%
FY2023Dec 31, 2023$20.25M+3.0%
FY2022Dec 31, 2022$19.65M+14.1%
FY2021Dec 31, 2021$17.22M+288.4%
FY2020Dec 31, 2020$4.43M+20.1%
FY2019Dec 31, 2019$3.69M+0.4%
FY2018Dec 31, 2018$3.68M+11.5%
FY2017Dec 31, 2017$3.30M+53.1%
FY2016Dec 31, 2016$2.15M-16.0%
FY2015Dec 31, 2015$2.57M-34.9%
FY2014Dec 31, 2014$3.94M-19.7%
FY2013Dec 31, 2013$4.91M+227.2%
FY2012Dec 31, 2012$1.50M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.10M-43.6%
Q1 FY2026Mar 31, 2026$2.39M-41.9%
Q4 FY2025Dec 31, 2025$2.63M-50.1%
Q3 FY2025Sep 30, 2025$3.33M-38.9%
Q2 FY2025Jun 30, 2025$3.72M-45.4%
Q1 FY2025Mar 31, 2025$4.11M-38.2%
Q4 FY2024Dec 31, 2024$5.28M+25.9%
Q3 FY2024Sep 30, 2024$5.45M-3.9%
Q2 FY2024Jun 30, 2024$6.81M+30.4%
Q1 FY2024Mar 31, 2024$6.64M+28.6%
Q4 FY2023Dec 31, 2023$4.20M-12.3%
Q3 FY2023Sep 30, 2023$5.67M+17.9%
Q2 FY2023Jun 30, 2023$5.22M+26.2%
Q1 FY2023Mar 31, 2023$5.17M-12.9%
Q4 FY2022Dec 31, 2022$4.78M-10.0%
Q3 FY2022Sep 30, 2022$4.80M-12.8%
Q2 FY2022Jun 30, 2022$4.14M+10.6%
Q1 FY2022Mar 31, 2022$5.93M+123.2%
Q4 FY2021Dec 31, 2021$5.32M+273.6%
Q3 FY2021Sep 30, 2021$5.51M+477.1%
Q2 FY2021Jun 30, 2021$3.74M+353.6%
Q1 FY2021Mar 31, 2021$2.66M+115.7%
Q4 FY2020Dec 31, 2020$1.42M+69.4%
Q3 FY2020Sep 30, 2020$954.00K+11.1%
Q2 FY2020Jun 30, 2020$825.00K-16.8%
Q1 FY2020Mar 31, 2020$1.23M+22.9%
Q4 FY2019Dec 31, 2019$840.00K-9.4%
Q3 FY2019Sep 30, 2019$859.00K-13.8%
Q2 FY2019Jun 30, 2019$991.00K-1.9%
Q1 FY2019Mar 31, 2019$1.00M+35.0%
Q4 FY2018Dec 31, 2018$927.00K+9.4%
Q3 FY2018Sep 30, 2018$997.00K+25.1%
Q2 FY2018Jun 30, 2018$1.01M-14.7%
Q1 FY2018Mar 31, 2018$742.00K+58.2%
Q4 FY2017Dec 31, 2017$847.00K+46.8%
Q3 FY2017Sep 30, 2017$797.00K+20.9%
Q2 FY2017Jun 30, 2017$1.18M–
Q1 FY2017Mar 31, 2017$469.00K–
Q4 FY2016Dec 31, 2016$577.00K–
Q3 FY2016Sep 30, 2016$659.00K–

More DarioHealth figures

See a number that looks wrong?